目的 观察Ahmed青光眼阀植入术联合玻璃体切除术治疗新生血管性青光眼(NVG)的临床效果.方法 NVG患者34例(36眼)行玻璃体切除联合睫状体平坦部玻璃体腔Ahmed青光眼阀植入术.结果 术后追踪随访3～15个月,平均8.2个月.术前平均眼压36.87 mm Hg(25.00～58.00 mm Hg),术后13.59 mm Hg(9.00～23.64 mm Hg).患者术前平均使用降眼压药物种类2.82种(2～5种),术后0.64种(0～2种).术后25眼视力均不同程度提高.有7眼术后出现不同类型并发症,其中大泡性角膜病变2眼,脉络膜脱离2眼,医源性白内障1眼,玻璃体腔积血1眼,青光眼阀暴露1眼.结论 Ahmed青光眼阀植入术联合玻璃体切除术可以有效地治疗NVG.%Objective To evaluate the effects of Ahmed glaucoma valve implant combined with vitrectomy for neovascular glau coma(NVG). Methods 34 patients (36 eyes)with NVG were undergone vitrectomy and Ahmed glaucoma valve implant. Results Mean preoperative IOP was 36.87 mm Hg (25-58 mm Hg)and 13.59 mm Hg (9-23.64 mm Hg)postoperatively,and mean number hypotensive drugs was decreased from 2.82 (2-5) before surgery to 0.64 (0-2)after it. Visual acuity in 25 eyes were improved in varying degree. There were 7 eyes of each of the following adverse events: bullous keratopathy(2 eyes),detachment of choroid(2 eyes), iatrogenic cataract (1 eye), hemorrhage of vitreous cavity glaucoma (1 eye), valve exposure (1 eye). Conclusion Ahmed glaucoma valve implant combined with vitrectomy seems to be a viable and safe surgical option in the management of NVG.
展开▼
